Respiratory disorders are very prevalent and high-incidence group of diseases having severe impacts on humanhealth in the world. Some of the respiratory disorders are difficult to diagnose and treat, such as chronicobstructive pulmonary disease, asthma, lungs cancer, and pulmonary tuberculosis. Lungs cancer is the secondmost common cancer globally. Nano-delivery technologies have a great potential to improve the drug targetingin a specific area of infections in respiratory disease treatment. Not only nanoparticles concentrate the drug atspecific-disease sites but also reduce the drug degradation and drug loss simultaneously. Sedimentation,nebulizers, carbon nanodots, and stimulus-responsive nanoparticles are currently being explored to use as asource for delivering nanodrugs to treat lungs cancer. Various nanoparticles such as steroids, salbutamol,liposome-mediated, and polystyrene are used in the treatment of asthma and preterm birth diseases. Thisstudy focused on different kinds of nanoparticles like gold, solid lipid nanoparticles (NPs), steroidal andliposome-mediated nanoparticles which are used to treat different pulmonary or respiratory disorders and alsoexamine the current therapeutic techniques for the diagnosis of lung diseases and therapy using nanoscalebasedinhalers.
CITATION STYLE
Deeba, F., Umer, F., & Nainan, D. (2021). Applications of Nanoparticles in Treatment of Respiratory Disorders. Life and Science, 3(1), 8. https://doi.org/10.37185/lns.1.1.186
Mendeley helps you to discover research relevant for your work.